Results
|
|
321.
|
|
|
|
322.
|
|
|
|
323.
|
|
|
|
324.
|
Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif. [electronic resource] by
- Jurk, Marion
- Chikh, Ghania
- Schulte, Bettina
- Kritzler, Andrea
- Richardt-Pargmann, Denise
- Lampron, Catherine
- Luu, Rachel
- Krieg, Arthur M
- Vicari, Alain P
- Vollmer, Jörg
Producer: 20111103
In:
Nucleic acid therapeutics vol. 21
Availability: No items available.
|
|
|
325.
|
Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. [electronic resource] by
- Gagnon, Keith T
- Pendergraff, Hannah M
- Deleavey, Glen F
- Swayze, Eric E
- Potier, Pierre
- Randolph, John
- Roesch, Eric B
- Chattopadhyaya, Jyoti
- Damha, Masad J
- Bennett, C Frank
- Montaillier, Christophe
- Lemaitre, Marc
- Corey, David R
Producer: 20101230
In:
Biochemistry vol. 49
Availability: No items available.
|
|
|
326.
|
|
|
|
327.
|
Novel targeted therapies for eosinophilic disorders. [electronic resource] by
- Wechsler, Michael E
- Fulkerson, Patricia C
- Bochner, Bruce S
- Gauvreau, Gail M
- Gleich, Gerald J
- Henkel, Tim
- Kolbeck, Roland
- Mathur, Sameer K
- Ortega, Hector
- Patel, Jatin
- Prussin, Calman
- Renzi, Paolo
- Rothenberg, Marc E
- Roufosse, Florence
- Simon, Dagmar
- Simon, Hans-Uwe
- Wardlaw, Andrew
- Weller, Peter F
- Klion, Amy D
Producer: 20121107
In:
The Journal of allergy and clinical immunology vol. 130
Availability: No items available.
|
|
|
328.
|
|
|
|
329.
|
|
|
|
330.
|
In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3' and 5' thiophosphate linkages. [electronic resource] by
- Duschmalé, Jörg
- Hansen, Henrik Frydenlund
- Duschmalé, Martina
- Koller, Erich
- Albaek, Nanna
- Møller, Marianne Ravn
- Jensen, Klaus
- Koch, Troels
- Wengel, Jesper
- Bleicher, Konrad
Producer: 20200318
In:
Nucleic acids research vol. 48
Availability: No items available.
|
|
|
331.
|
|
|
|
332.
|
|
|
|
333.
|
|
|
|
334.
|
|
|
|
335.
|
|
|
|
336.
|
|
|
|
337.
|
|
|
|
338.
|
|
|
|
339.
|
|
|
|
340.
|
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer. [electronic resource] by
- Adjei, Alex A
- Dy, Grace K
- Erlichman, Charles
- Reid, Joel M
- Sloan, Jeff A
- Pitot, Henry C
- Alberts, Steven R
- Goldberg, Richard M
- Hanson, Lorelei J
- Atherton, Pamela J
- Watanabe, Tanya
- Geary, Richard S
- Holmlund, Jon
- Dorr, F Andrew
Producer: 20030717
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 9
Availability: No items available.
|